Canada markets open in 6 hours 18 minutes

NextCure, Inc. (NXTC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.7800+0.0600 (+2.21%)
At close: 04:00PM EDT
2.9200 +0.14 (+5.04%)
After hours: 04:35PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    NextCure to Present at the Ladenburg Thalmann Healthcare Conference

    BELTSVILLE, Md., Sept. 22, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the Ladenburg Thalmann Healthcare Conference in New York City on Thursday, September 29th at 10 am ET. A live audio webcast will be available through the Investors section of the company’s website at www.n

  • Simply Wall St.

    With 37% ownership, NextCure, Inc. (NASDAQ:NXTC) has piqued the interest of institutional investors

    To get a sense of who is truly in control of NextCure, Inc. ( NASDAQ:NXTC ), it is important to understand the...

  • GlobeNewswire

    NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results

    On track to report data from all three clinical programsSecond quarter ending cash of $185.5 million expected to fund operations into the first quarter of 2024 BELTSVILLE, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today reported second quarter 2022 financial results and provided a business update. “